Publications by authors named "Kenneth R Hande"

Claim this Profile
L
Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumors.
Chanjuan Shi, Raul S Gonzalez, Zhiguo Zhao, Tatsuki Koyama, Toby C Cornish, Kenneth R Hande

Am J Clin Pathol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone cancer.
J Sybil Biermann, Douglas R Adkins, Mark Agulnik, Robert S Benjamin, Brian Brigman, Kenneth R Hande

J Natl Compr Canc Netw· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Signal transduction pathway analysis in desmoid-type fibromatosis: transforming growth factor-β, COX2 and sex steroid receptors.
Nicholas A Mignemi, Doha M Itani, John H Fasig, Vicki L Keedy, Kenneth R Hande

Cancer Sci· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Signal transduction pathway analysis in fibromatosis: receptor and nonreceptor tyrosine kinases.
Justin M M Cates, Jennifer O Black, Doha M Itani, John H Fasig, Vicki L Keedy, Kenneth R Hande

Hum Pathol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear p63 expression in osteoblastic tumors.
Michael E Kallen, Melinda E Sanders, Adriana L Gonzalez, Jennifer O Black, Vicki L Keedy, Kenneth R Hande

Tumour Biol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morphologic and immunophenotypic analysis of desmoid-type fibromatosis after radiation therapy.
Justin M M Cates, Jennifer Black, Carmen C Wolfe, Eric T Shinohara, Ginger E Holt, Kenneth R Hande

Hum Pathol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone cancer.
J Sybil Biermann, Douglas R Adkins, Robert S Benjamin, Brian Brigman, Warren Chow, Kenneth R Hande

J Natl Compr Canc Netw· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules.
George D Demetri, Sant P Chawla, Margaret von Mehren, Paul Ritch, Laurence H Baker, Kenneth R Hande

J Clin Oncol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing an in-training examination for fellows: the experience of the American Society of Clinical Oncology.
Frances A Collichio, Karen M Kayoumi, Kenneth R Hande, Richard E Hawkins, Janine L Hawley

J Clin Oncol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pharmacokinetics and safety of ABT-751, a novel, orally bioavailable sulfonamide antimitotic agent: results of a phase 1 study.
Kenneth R Hande, Anne Hagey, Jordan Berlin, Yingna Cai, Kysa Meek

Clin Cancer Res· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/pilot study of SU5416 (semaxinib) in combination with irinotecan/bolus 5-FU/LV (IFL) in patients with metastatic colorectal cancer.
Albert Craig Lockhart, Gillian F Cropp, Jordan D Berlin, Edwin Donnelly, Robert D Schumaker, Kenneth R Hande

Am J Clin Oncol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topoisomerase II inhibitors.
Danko Martincic, Kenneth R Hande

Cancer Chemother Biol Response Modif· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topoisomerase II inhibitors.
Kenneth R Hande

Cancer Chemother Biol Response Modif· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacokinetic study of prinomastat, a matrix metalloprotease inhibitor.
Kenneth R Hande, Mary Collier, Linda Paradiso, Jill Stuart-Smith, Mary Dixon

Clin Cancer Res· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I dose-escalation and pharmacokinetic study of brostallicin (PNU-166196A), a novel DNA minor groove binder, in adult patients with advanced solid tumors.
A Craig Lockhart, Martin Howard, Kenneth R Hande, Bruce J Roth, Jordan D Berlin

Clin Cancer Res· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topoisomerase II inhibitors.
JaNae M Clapp, Kenneth R Hande

Cancer Chemother Biol Response Modif· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis